➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
AstraZeneca
Colorcon
McKesson
Medtronic

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Hyaluronidase - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for hyaluronidase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
University of Wisconsin, MadisonPhase 4
Regeneron PharmaceuticalsPhase 2
Massachusetts Eye and Ear InfirmaryPhase 2

See all hyaluronidase clinical trials

Recent Litigation for hyaluronidase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC2018-11-09
Halozyme, Inc. v. Lee2016-12-19
PIECZENIK v. BAYER CORPORATION2010-05-04

See all hyaluronidase litigation

PTAB Litigation
PetitionerDate
2017-05-30
2017-01-31

See all hyaluronidase litigation

Company Disclosures: US Patents for hyaluronidase

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Halozyme Therap HYLENEX RECOMBINANT hyaluronidase recombinant human INJECTABLE;INJECTION 021859 001 2005-12-02   Start Trial Halozyme, Inc. (San Diego, CA) 2039-09-22 RX company
Halozyme Therap HYLENEX RECOMBINANT hyaluronidase recombinant human INJECTABLE;INJECTION 021859 001 2005-12-02   Start Trial Halozyme, Inc. (San Diego, CA) 2023-03-05 RX company
Halozyme Therap HYLENEX RECOMBINANT hyaluronidase recombinant human INJECTABLE;INJECTION 021859 001 2005-12-02   Start Trial Halozyme, Inc. (San Diego, CA) 2023-03-05 RX company
Halozyme Therap HYLENEX RECOMBINANT hyaluronidase recombinant human INJECTABLE;INJECTION 021859 001 2005-12-02   Start Trial Halozyme, Inc. (San Diego, CA) 2023-03-05 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for hyaluronidase

These patents were identified by searching patent claims

Supplementary Protection Certificates for hyaluronidase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013 028 Romania   Start Trial PRODUCT NAME: MICROPLASMINA; NATIONAL AUTHORISATION NUMBER: EU/1/13/819/001; DATE OF NATIONAL AUTHORISATION: 20130313; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/13/819/001; DATE OF FIRST AUTHORISATION IN EEA: 20130313
2013020 Lithuania   Start Trial PRODUCT NAME: OCRIPLASMINUM (MICROPLASMINUM); REGISTRATION NO/DATE: EU/1/13/819/001 20130313
2013000076 Germany   Start Trial PRODUCT NAME: MIKROPLASMIN; REGISTRATION NO/DATE: EU/1/13/819/001 20130313
C/GB13/057 United Kingdom   Start Trial PRODUCT NAME: OCRIPLASMIN; REGISTERED: UK EU/1/13/819/001 20130315
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Mallinckrodt
Dow
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.